0
0
9/11/23 at 5:37pm
Organization
Targetedonc.com
30 words
0
Comments
Ruchi Garg, MD, discusses the impact of targeted therapies studies in patients with early and recurrent endometrial cancer.
You are the first to view
https://www.targetedonc.com/view/molecular-subtyping-leads-to-new-targeted-trials-in-endometrial-cancer
Create an account
or login to join the discussion